Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Cancer Research|December 9, 2020
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte FunctionLinnéa La Fleur, Johan Botling, Fei He, et al.
Molecular & Cellular Proteomics : MCP|June 15, 2007
In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation methodMalin Jarvius, Janna Paulsson, Irene Weibrecht, et al.
European Journal of Haematology|November 10, 2009
Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006Ingrid Thörn, Erik Forestier, Britt Thuresson, et al.
Endocrine Pathology|June 9, 2026
Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical CarcinomaSamuel Backman, Fredrik Axling, Liang Zhang, et al.
Breast Cancer Research : BCR|January 9, 2010
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancerAslaug Aa Muggerud, Jo Anders Rønneberg, Fredrik Wärnberg, et al.
Cancer Letters|July 22, 2026
Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapyEmmanuel Nwadozi, Carina Strell, Sofia Nordling, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, et al.
Oncotarget|December 25, 2015
The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingErna Raja, Kalliopi Tzavlaki, Robin Vuilleumier, et al.
International Journal of Cancer|April 9, 2014
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerPatrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.
Pageof 13